CDMOP.PFD (Avid Bioservices) Other Current Payables : $0.00 Mil (As of Oct. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices Other Current Payables?

Avid Bioservices's Other Current Payables for the quarter that ended in Oct. 2024 was $0.00 Mil.

Avid Bioservices Other Current Payables Historical Data

The historical data trend for Avid Bioservices's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Other Current Payables Chart

Avid Bioservices Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Other Current Payables

Get a 7-Day Free Trial

Avid Bioservices Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Other Current Payables	Get a 7-Day Free Trial															-	-	-	-	-

Avid Bioservices Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Avid Bioservices Other Current Payables Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.